SCNI
Scinai Immunotherapeutics
SCNI
SCNI
5 hedge funds and large institutions have $177K invested in Scinai Immunotherapeutics in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
VIA
1
Vantage Investment Advisors
State College,
Pennsylvania
|
$62K |
2 |
2
Bank of Montreal
Toronto,
Ontario, Canada
|
$55K |
3 |
3
UBS Group
Zurich,
Switzerland
|
$13K |
Top Sellers
1 |
1
Jane Street
New York
|
$46K |
2 |
VKH
2
Virtu KCG Holdings
New York
|
$0 |
3 |
TRCT
3
Tower Research Capital (TRC)
New York
|
$0 |
4 |
4
Citigroup
New York
|
$1K |